Corante

About this author
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev
Receive by email

GUEST AUTHOR ARCHIVES
THE NEURO REVOLUTION
TNRCoverWeb120.jpg Buy on Amazon
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

Brain Waves

« Summer Funny - BrainFreeze Video | Main | UC Merced Opens Today »

September 1, 2005

Treating Pain - Special Neurotech Insights Issue

Email This Entry

Posted by Zack Lynch

We all feel pain. Some 87 million Americans and over 290 million individuals worldwide suffer from some form of chronic pain. Sales of therapeutics for pain management reached over $20 billion last year, up 11%.

aug 31b cover.jpgTo learn more about the past, present and future of the pain management market then don't miss the latest issue of Neurotech Insights - the neurotechnology investment newsletter. Included in this issue:

-Next Generation Pain Treatments (in-depth analysis with latest clinical trials)
-Interview with Pain Therapeutics CEO, Remi Barbier
-Discussion of neurostimulation treatments for pain management
-Market analysis of public companies (RNVS, CEPH, MDT, DOVP, NTII, SHPGY)
-Deals, alliances and financings
-Neurotech Index performance (companies treating neurological diseases)

If you are an investor, corporate executive, researcher, or someone who suffers from chronic pain I recommend picking up the latest copy of Neurotech Insights - the biweekly neurotechnology investment newsletter.

Comments (1) + TrackBacks (0) | Category: Neurotech Industry


COMMENTS

1. bill on September 6, 2005 2:22 PM writes...

I would think if you're going to devote an entire blog column to a magazine issue that you would have the magazine (or at least 1 or 2 articles) freely available to peruse. In light of that, the column appears to provide nothing more than an advertisement to purchase (for $50) one of your products. I suppose it's your blog though.

Permalink to Comment


EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
NIO Unveils Top 10 Neuroscience Trends for 2009
NIO CEO Media Tour in NYC Gets Results
O Neurocaster
Manuscript Sent to Japan
2009 Stem Cell Trendsetters in Neurology and Psychiatry
Mental Health Parity Legislation Passes within Financial Package
Holy Neurofinancial Meltdown Bernanke
Interest in Neuropolicy Grows